Carter's (CRI) Tops Q1 EPS by 43c; Q2 guidance misses
Get Alerts CRI Hot Sheet
Price: $33.55 +1.21%
EPS Growth %: +20.3%
Financial Fact:
Net income: 80.81M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +20.3%
Financial Fact:
Net income: 80.81M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Carter's (NYSE: CRI) reported Q1 EPS of $0.98, $0.43 better than the analyst estimate of $0.55. Revenue for the quarter came in at $696 million versus the consensus estimate of $652.18 million.
GUIDANCE:
Carter's sees Q2 2023 EPS of $0.40-$0.50, versus the consensus of $0.75. Carter's sees Q2 2023 revenue of $590-605 billion, versus the consensus of $625.8 billion.
Carter's sees FY2023 EPS of $6.15, versus the consensus of $5.90. Carter's sees FY2023 revenue of $3 billion, versus the consensus of $3.01 billion.
For earnings history and earnings-related data on Carter's (CRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
- Planet Labs (PL) Tops Q2 EPS by 4c, Offers Guidance
- Asana, Inc. (ASAN) Tops Q2 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share